Erratum: Muscle lipogenesis balances insulin sensitivity and strength through calcium signaling (Journal of Clinical Investigation (2013) 123:3 (1229-1240) DOI :10.1172/JCI65726);Muscle lipogenesis balances insulin sensitivity and strength through calcium signaling

Journal of Clinical Investigation

Volumn 123, Issue 3, 2013, Pages 1229-1240

  Funai, Katsuhiko ^a   Song, Haowei ^a   Yin, Li ^a   Lodhi, Irfan J ^a   Wei, Xiaochao ^a   Yoshino, Jun ^a   Coleman, Trey ^a   Semenkovich, Clay F ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE PHOSPHATE; ADENOSINE TRIPHOSPHATASE (CALCIUM); ADENYLATE KINASE; CERAMIDE; FATTY ACID SYNTHASE; PHOSPHOLIPID;

ARTICLE; CALCIUM SIGNALING; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; ENDOPLASMIC RETICULUM; ENZYME ACTIVATION; ENZYME ACTIVITY; FAT INTAKE; INSULIN SENSITIVITY; LIPOGENESIS; MOUSE; MUSCLE LEVEL; MUSCLE STRENGTH; MUSCLE WEAKNESS; NONHUMAN; OBESITY; PHYSICAL PERFORMANCE; PRIORITY JOURNAL; SARCOPLASMIC RETICULUM; SIGNAL TRANSDUCTION; SKELETAL MUSCLE;

EID: 84874624368     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI72174     Document Type: Erratum

References (60)

1. Seshasai SR, et al. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med. 2011;364(9):829-841.
2. Saltiel AR. New perspectives into the molecular pathogenesis and treatment of type 2 diabetes. Cell. 2001;104(4):517-529. (Pubitemid 32201947)
3. Schenk S, Saberi M, Olefsky JM. Insulin sensitivity: modulation by nutrients and inflammation. J Clin Invest. 2008;118(9):2992-3002.
4. DeFronzo RA, Gunnarsson R, Bjorkman O, Olsson M, Wahren J. Effects of insulin on peripheral and splanchnic glucose metabolism in noninsulindependent (type II) diabetes mellitus. J Clin Invest. 1985;76(1):149-155. (Pubitemid 15240430)
5. McGarry JD. What if Minkowski had been ageusic? An alternative angle on diabetes. Science. 1992; 258(5083):766-770.
6. Ferreira LD, Pulawa LK, Jensen DR, Eckel RH. Overexpressing human lipoprotein lipase in mouse skeletal muscle is associated with insulin resistance. Diabetes. 2001;50(5):1064-1068. (Pubitemid 32377287)
7. Liu L, Zhang Y, Chen N, Shi X, Tsang B, Yu YH. Upregulation of myocellular DGAT1 augments triglyceride synthesis in skeletal muscle and protects against fat-induced insulin resistance. J Clin Invest. 2007;117(6):1679-1689. (Pubitemid 46871352)
8. Haemmerle G, et al. Defective lipolysis and altered energy metabolism in mice lacking adipose triglyceride lipase. Science. 2006;312(5774):734-737.
9. Choi CS, et al. Continuous fat oxidation in acetyl-CoA carboxylase 2 knockout mice increases total energy expenditure, reduces fat mass, and improves insulin sensitivity. Proc Natl Acad Sci U S A. 2007; 104(42):16480-16485.
10. Koonen DP, et al. Alterations in skeletal muscle fatty acid handling predisposes middle-aged mice to diet-induced insulin resistance. Diabetes. 2010; 59(6):1366-1375.
11. Wang H, et al. Skeletal muscle-specific deletion of lipoprotein lipase enhances insulin signaling in skeletal muscle but causes insulin resistance in liver and other tissues. Diabetes. 2009;58(1):116-124.
12. Funai K, Semenkovich CF. Skeletal muscle lipid flux: running water carries no poison. Am J Physiol Endocrinol Metab. 2011;301(2):E245-E251.
13. Muoio DM, Neufer PD. Lipid-induced mitochondrial stress and insulin action in muscle. Cell Metab. 2012;15(5):595-605.
14. Maier T, Leibundgut M, Ban N. The crystal structure of a mammalian fatty acid synthase. Science. 2008;321(5894):1315-1322.
15. Pender C, Trentadue AR, Pories WJ, Dohm GL, Houmard JA, Youngren JF. Expression of genes regulating malonyl-CoA in human skeletal muscle. J Cell Biochem. 2006;99(3):860-867. (Pubitemid 44522004)
16. Lodhi IJ, Wei X, Semenkovich CF. Lipoexpediency: de novo lipogenesis as a metabolic signal transmitter. Trends Endocrinol Metab. 2011;22(1):1-8.
17. Chakravarthy MV, et al. Identification of a physiologically relevant endogenous ligand for PPARalpha in liver. Cell. 2009;138(3):476-488.
18. Finck BN, et al. A potential link between muscle peroxisome proliferator- activated receptor-alpha signaling and obesity-related diabetes. Cell Metab. 2005;1(2):133-144. (Pubitemid 43960595)
19. Kersten S. Mechanisms of nutritional and hormonal regulation of lipogenesis. EMBO Rep. 2001; 2(4):282-286. (Pubitemid 32401521)
20. Coupe C, Perdereau D, Ferre P, Hitier Y, Narkewicz M, Girard J. Lipogenic enzyme activities and mRNA in rat adipose tissue at weaning. Am J Physiol. 1990;258(1 pt 1):E126-E133. (Pubitemid 20068589)
21. Kraegen EW, James DE, Storlien LH, Burleigh KM, Chisholm DJ. In vivo insulin resistance in individual peripheral tissues of the high fat fed rat: assessment by euglycaemic clamp plus deoxyglucose administration. Diabetologia. 1986;29(3):192-198. (Pubitemid 16137030)
22. Chakravarthy MV, et al. "New" hepatic fat activates PPARalpha to maintain glucose, lipid, and cholesterol homeostasis. Cell Metab. 2005;1(5):309-322. (Pubitemid 43977168)
23. Miniou P, Tiziano D, Frugier T, Roblot N, Le Meur M, Melki J. Gene targeting restricted to mouse striated muscle lineage. Nucleic Acids Res. 1999;27(19):e27.
24. Samuel VT, Shulman GI. Mechanisms for insulin resistance: common threads and missing links. Cell. 2012;148(5):852-871.
25. Kane S, et al. A method to identify serine kinase substrates. Akt phosphorylates a novel adipocyte protein with a Rab GTPase-activating protein (GAP) domain. J Biol Chem. 2002;277(25):22115-22118. (Pubitemid 34967174)
26. Cartee GD, Funai K. Exercise and insulin: Convergence or divergence at AS160 and TBC1D1? Exerc Sport Sci Rev. 2009;37(4):188-195.
27. Funai K, Cartee GD. Inhibition of contraction-stimulated AMP-activated protein kinase inhibits contraction-stimulated increases in PAS-TBC1D1 and glucose transport without altering PAS-AS160 in rat skeletal muscle. Diabetes. 2009;58(5):1096-1104.
28. Chen S, Murphy J, Toth R, Campbell DG, Morrice NA, Mackintosh C. Complementary regulation of TBC1D1 and AS160 by growth factors, insulin and AMPK activators. Biochem J. 2008;409(2):449-459. (Pubitemid 351184963)
29. Steinberg GR, et al. Tumor necrosis factor alphainduced skeletal muscle insulin resistance involves suppression of AMP-kinase signaling. Cell Metab. 2006;4(6):465-474. (Pubitemid 44834113)
30. Fujii N, et al. Ablation of AMP-activated protein kinase alpha2 activity exacerbates insulin resistance induced by high-fat feeding of mice. Diabetes. 2008;57(11):2958-2966.
31. Seale P, et al. PRDM16 controls a brown fat/skeletal muscle switch. Nature. 2008;454(7207):961-967.
32. Hardie DG. AMP-activated protein kinase: an energy sensor that regulates all aspects of cell function. Genes Dev. 2011;25(18):1895-1908.
33. Razani B, et al. Fatty acid synthase modulates homeostatic responses to myocardial stress. J Biol Chem. 2011;286(35):30949-30961.
34. Xie X, et al. C2 domain-containing phosphoprotein CDP138 regulates GLUT4 insertion into the plasma membrane. Cell Metab. 2011;14(3):378-389.
35. Kramer HF, Taylor EB, Witczak CA, Fujii N, Hirshman MF, Goodyear LJ. Calmodulin-binding domain of AS160 regulates contraction- but not insulinstimulated glucose uptake in skeletal muscle. Diabetes. 2007;56(12):2854-2862. (Pubitemid 350223618)
36. Wright DC, Hucker KA, Holloszy JO, Han DH. Ca2+ and AMPK both mediate stimulation of glucose transport by muscle contractions. Diabetes. 2004;53(2):330-335. (Pubitemid 38174547)
37. Wei X, et al. De novo lipogenesis maintains vascular homeostasis through endothelial nitric-oxide synthase (eNOS) palmitoylation. J Biol Chem. 2011;286(4):2933-2945.
38. Wei X, et al. Fatty acid synthase modulates intestinal barrier function through palmitoylation of mucin 2. Cell Host Microbe. 2012;11(2):140-152.
39. Gustavsson M, Traaseth NJ, Veglia G. Activating and deactivating roles of lipid bilayers on the Ca(2+)-ATPase/phospholamban complex. Biochemistry. 2011;50(47):10367-10374.
40. Fu S, et al. Aberrant lipid metabolism disrupts calcium homeostasis causing liver endoplasmic reticulum stress in obesity. Nature. 2011;473(7348):528-531.
41. Pan Y, et al. Targeted disruption of the ATP2A1 gene encoding the sarco(endo)plasmic reticulum Ca2+ ATPase isoform 1 (SERCA1) impairs diaphragm function and is lethal in neonatal mice. J Biol Chem. 2003;278(15):13367-13375. (Pubitemid 36800109)
42. Goonasekera SA, et al. Mitigation of muscular dystrophy in mice by SERCA overexpression in skeletal muscle. J Clin Invest. 2011;121(3):1044-1052.
43. Maclennan DH, Zvaritch E. Mechanistic models for muscle diseases and disorders originating in the sarcoplasmic reticulum. Biochim Biophys Acta. 2011;1813(5):948-964.
44. Lodhi IJ, et al. Inhibiting adipose tissue lipogenesis reprograms thermogenesis and PPARgamma activation to decrease diet-induced obesity. Cell Metab. 2012;16(2):189-201.
45. Chavez JA, Summers SA. A ceramide-centric view of insulin resistance. Cell Metab. 2012;15(5):585-594.
46. Chakravarthy MV, et al. Brain fatty acid synthase activates PPARalpha to maintain energy homeostasis. J Clin Invest. 2007;117(9):2539-2552. (Pubitemid 47494355)
47. Schneider JG, et al. Macrophage fatty-acid synthase deficiency decreases diet-induced atherosclerosis. J Biol Chem. 2010;285(30):23398-23409.
48. Jensen-Urstad AP, Semenkovich CF. Fatty acid synthase and liver triglyceride metabolism: Housekeeper or messenger? Biochim Biophys Acta. 2012; 1821(5):747-753.
49. Jans A, et al. Transcriptional metabolic inflexibility in skeletal muscle among individuals with increasing insulin resistance. Obesity. 2011;19(11):2158-2166.
50. Aagaard L, Nawrocki A, Madsen K. Effect of highfat diet on sarcoplasmic reticulum Ca(++)-ATPase activity in different types of rat skeletal muscle. Rocz Akad Med Bialymst. 2002;47:31-39.
51. Saltiel AR. Insulin resistance in the defense against obesity. Cell Metab. 2012;15(6):798-804.
52. Racz G, Szabo A, Ver A, Zador E. The slow sarco/ endoplasmic reticulum Ca2+-ATPase declines independently of slow myosin in soleus muscle of diabetic rats. Acta Biochim Polonica. 2009;56(3):487-493.
53. Algenstaedt P, Antonetti DA, Yaffe MB, Kahn CR. Insulin receptor substrate proteins create a link between the tyrosine phosphorylation cascade and the Ca2+-ATPases in muscle and heart. J Biol Chem. 1997;272(38):23696-23702. (Pubitemid 27410944)
54. Wu M, et al. Antidiabetic and antisteatotic effects of the selective fatty acid synthase (FAS) inhibitor platensimycin in mouse models of diabetes. Proc Natl Acad Sci U S A. 2011;108(13):5378-5383.
55. Bernal-Mizrachi C, et al. Respiratory uncoupling lowers blood pressure through a leptin-dependent mechanism in genetically obese mice. Arterioscler Thromb Vasc Biol. 2002;22(6):961-968. (Pubitemid 34655224)
56. Yoshino J, Mills KF, Yoon MJ, Imai S. Nicotinamide mononucleotide, a key NAD(+) intermediate, treats the pathophysiology of diet- and age-induced diabetes in mice. Cell Metab. 2011;14(4):528-536.
57. Gan Z, et al. The nuclear receptor PPARbeta/delta programs muscle glucose metabolism in cooperation with AMPK and MEF2. Genes Dev. 2011; 25(24):2619-2630.
58. Moore L, Chen T, Knapp HR Jr, Landon EJ. Energydependent calcium sequestration activity in rat liver microsomes. J Biol Chem. 1975;250(12):4562-4568.
59. Ullman AH, White HB 3rd. Assay of fatty acid synthase using a bicyclic dione as substrate. Methods Enzymol. 1981;72:303-306.
60. Pizer ES, et al. Malonyl-coenzyme-A is a potential mediator of cytotoxicity induced by fatty-acid synthase inhibition in human breast cancer cells and xenografts. Cancer Res. 2000;60(2):213-218. (Pubitemid 30070736)